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Abstract
Background: Genes essential for bacterial growth are of particular scientific interest. Many putative essential genes have
been identified or predicted in several species, however, little is known about gene expression requirement stringency,
which may be an important aspect of bacterial physiology and likely a determining factor in drug target development.
Methodology/Principal Findings: Working from the premise that essential genes differ in absolute requirement for growth,
we describe silencing of putative essential genes in E. coli to obtain a titration of declining growth rates and transcript levels
by using antisense peptide nucleic acids (PNA) and expressed antisense RNA. The relationship between mRNA decline and
growth rate decline reflects the degree of essentiality, or stringency, of an essential gene, which is here defined by the
minimum transcript level for a 50% reduction in growth rate (MTL50). When applied to four growth essential genes, both
RNA silencing methods resulted in MTL50 values that reveal acpP as the most stringently required of the four genes
examined, with ftsZ the next most stringently required. The established antibacterial targets murA and fabI were less
stringently required.
Conclusions: RNA silencing can reveal stringent requirements for gene expression with respect to growth. This method may
be used to validate existing essential genes and to quantify drug target requirement.
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Introduction
Progress in antimicrobial discovery has been slow during recent
decades [1] despite large-scale efforts to identify genes essential for
growth in conserved pathways of Escherichia coli [2] and Staphylococcus
aureus [3]. The drug discovery process involves essential gene
identification through various methods such as chromosomal
deletions [2] and experimentally reduced genomes [4], followed
by studies of gene product interactions through tandem affinity
purification [5] and/or mathematical models [6]. Potential drug
targets are then subjected to high-throughput screening for
inhibitors, which often fail at the cellular level in ‘‘hit-to-lead’’
stages of development due to several factors [7], such as gene
function redundancy [8]. Also, for certain essential genes we suspect
that there may be a low degree of gene expression requirement for
bacterial viability. Despite evidence for differential requirement in
growth essential genes [9], and initial efforts at scoring essentiality
[2,10], there has not been a quantitative method to determine the
expression requirement for essential genes so that only stringently
required targets are considered further for drug development. This
study focuses on measuring differences between suspected essential
genes in terms of their degree of requirement for cell viability,
referred to here as stringency, in E. coli.
We hypothesize that growth essential genes differ in require-
ment stringencies, and that these differences can be revealed by
measuring the relationships between specific mRNA decreases and
bacterial growth rate decline. The aim of this study is to measure
the growth stringency requirement E. coli genes using antisense
gene silencing, so as to evaluate degree of essentiality for cell
viability. Two antisense gene control strategies for bacteria are
used - synthetic antisense peptide nucleic acids (PNAs) and plasmid
expression of antisense RNA sequences. Both methods are capable
of modulating essential genes in situ in E. coli [11,12] and S. aureus
[13,14], and certain antisense agents can inhibit Mycobacteria
[15,16]. Therefore, RNA silencing using specific antisense
sequences provides an approach to measure gene requirement
stringency.
Four genes, acpP, fabI, ftsZ and murA were selected for this study
for the following reasons: (a) each gene has been shown
experimentally to be essential for growth in E. coli
[2,4,17,18,19,20], (b) they have been studied as antimicrobial
targets [21,22,23], (c) the gene products have different cellular
functions and (d) each gene can be silenced potentially without
downstream effects [24,25]. Interactions between FabI and its
specific inhibitor, triclosan, are well understood [26]. The fabI
gene encodes enoyl ACP reductase, which catalyzes fatty acid
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acetylglucosamine enolpyruvyl transferase (encoded for by murA),
which catalyzes the synthesis of peptidoglycan from N-acetylglu-
cosamine acid and phosphoenoylpyruvate [10,18,27]. MurA is
specifically inhibited by phosphomycin [28], and the mechanism
of inhibition is well understood [29]. The protein function of FtsZ
has also been studied in detail, and FtsZ is the focus of much assay
development to discover effective inhibitors [30]. The ftsZ gene
encodes a tubulin-like protein that polymerizes to form a Z-ring as
a scaffold for cell division [31]. ACP or acyl carrier protein is
encoded by acpP. ACP is an interesting drug target because,
although it has been shown to be central to bacterial fatty acid
biosynthesis [32,33], specific protein inhibitors have not yet been
discovered. Nevertheless, acpP was shown to be an effective
antisense target for treatment of bacterial infections in vivo [34,35]
and the gene product can be inhibited [36].
In principle, the extent to which partial mRNA inhibition limits
growth should reflect how stringently required the targeted mRNA
is for bacterial viability. The specificities of antisense PNA and
expressed antisense RNA silencing of the four selected target genes
were assessed by conducting rescue experiments, where over-
expression of the four target genes in different strains comple-
mented the effects of the cognate silencers. To titrate down
essential gene expression and obtain measured responses in E. coli,
growth, we used gene specific antisense PNA and IPTG-induced
expression of antisense sequences. This concept enables quantita-
tive analyses of mRNA silencing and growth reduction, which are
not possible using knockout approaches. We show that the
essential genes differed in mRNA inhibition to growth inhibition
profiles, demonstrating that the relationship between transcript
levels and growth rate reflects the requirement stringencies of
essential genes.
Results
Specificity of antisense RNA PNA and expressed
antisense RNA
To silence the four selected target genes using the two different
silencing methods, we first needed to design, test and validate
several new silencers. Fortunately, we were able to use previously
developed silencers for acpP and fabI, and we used similar design
guidelines for the additional silencers needed for this study. We
found that all eight silencers are able to inhibit E. coli growth. Also,
both PNA and expressed antisense RNA silencers displayed gene
and sequence selective effects. Nevertheless, to ensure that all
silence mainly the target gene, we carried out a set of rescue
experiments where the RNA silencers were used under conditions
that inhibited growth and we tested whether growth could be
rescued by over-expression of the target gene open reading frame
(ORF) from a plasmid. This transcomplementation strategy
provides a more strict control of specificity relative to controls
that involve sense, scrambled or irrelevant sequences, because it
takes into account all transcript sequences present in the bacterial
cell and the effector sequences remain unchanged. We designed
antisense PNA specific for acpP (Ec108), fabI (Ec107), ftsZ (Ec326),
and murA (Ec330) using optimal parameters for gene silencing
[37,38] (Table 1). To test PNA specificity, we constructed four
DH5a strains containing either pBAD-acpP, pBAD-fabI, pBAD-
ftsZ or pBAD-murA. Each strain was grown in the presence of
antisense PNA specific to the target gene cloned into pBAD, and
either with or without the addition of L-arabinose for target gene
over-expression. Without L-arabinose, strains did not grow but
upon induction by L-arabinose, were resistant to the growth
inhibitory effects of the PNA (Figure 1). To test specificity of
antisense expressed from plasmids, we constructed another four
DH5a strains containing either pBAD-acpP+pHNA, pBAD-
fabI+pHN682, pBAD-ftsZ+pHNZ or pBAD-murA+pHNM. Each
strain was grown in the presence of IPTG for induction of
expressed antisense, and either with or without the addition of L-
arabinose to induce target gene over-expression. Without L-
arabinose, growth of strains was inhibited, and L-arabinose
addition complemented gene silencing and allowed strains to
grow in the presence of expressed antisense (Figure 1). The results
from the rescue experiments demonstrate that the eight silencers
display gene selective growth inhibition.
Titration of essential gene expression and its effect of
growth rate
To test the hypothesis that essential genes are differentially
required to maintain a similar level of growth, we titrated down
the growth rate of E. coli using either antisense PNA or expressed
antisense and determined mRNA levels of the targeted essential
gene. To enable parallel analyses of multiple genes in this study,
we used RT-PCR to quantify mRNA levels and assume it as a
proxy to protein measure in bacteria [39]. For PNA-mediated
antisense effects, we used the hyper-permeable E. coli strain AS19
to obtain efficient uptake [40]. Six doses of each antisense PNA
were selected in order to achieve a titration in E. coli growth rate
reduction. Hence, the dose range of each antisense PNA was
unique, resulting in growth inhibition in a dose dependent manner
(Figure 2). For expressed antisense, plasmids were transformed
into TOP10 E. coli cells (Table 2) and antisense RNA expression
was induced using IPTG at concentrations that provided a
titration of decreasing growth rates (not shown).
Both antisense PNA and expressed antisense specifically
silenced mRNA of essential genes acpP, fabI, ftsZ or murA,a s
determined by analyses of transcript levels over an appropriate
range of inhibitory but not lethal doses (Figure 3). Decreases in
essential gene transcripts corresponded to decreases in bacterial
growth rates (PNA data: R
2 for acpP, fabI, ftsZ, murA=0.87, 0.63,
0.89, 0.45), although the response was non-linear. It should be
noted that the growth profiles observed for ftsZ-inhibited cultures,
which displayed a rise and then a fall in culture turbidity, were
consistent with a cell-division effect observed previously, where
cells elongate without dividing [41,42]. Phenotypic effects of ftsZ-
inhibited cultures were confirmed by microscopy, revealing
extremely elongated cells compared to untreated cells and cells
treated with other PNAs. Cell phenotypes for antisense-expressing
cells were similar to that of antisense PNA-treated cells (Figure 4).
Essential gene stringencies and minimum level transcript
50 as a measure
The relationship between the decrease in mRNA and growth
rate determined by both silencing methods indicates that the
requirement for the four essential genes is unequal, with some
genes more stringently required than others. Indeed, expressing
relative growth rate as a function of relative mRNA level (Figure 5)
showed that the minimum level of mRNA needed for 50% cell
viability is in the order acpP .ftsZ.murA.fabI by antisense PNA.
That is, a large number of acpP transcripts (approximately 0.65
relative value or 65% of a normal cell) is required to maintain 50%
cell viability, compared to ftsZ (38%), murA (30%) and fabI (20%)
transcripts. In other words, a small decrease in acpP mRNA led to
a large decrease in bacterial growth rates, while decreases in ftsZ
mRNA had proportional effects on growth rates and large
decreases in fabI and murA mRNA were required to obtain a
small decrease in growth rates. Gene stringency was in the order
E. coli Gene Stringency
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e6061Figure 1. Transcomplementation of antisense PNA and expressed antisense RNA effects on growth by target gene over-expression.
Essential gene over-expression was induced by L-arabinose at indicated concentrations. PNAs were added to a final concentration of 4 mM.
Concentrations of IPTG used for induction of acpP-, fabI-, ftsZ- and murA-antisense expression were 200 mM, 1 mM, 100 mM and 75 mM, respectively.
doi:10.1371/journal.pone.0006061.g001
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differs from the PNA data in that murA is the least stringently
required essential gene for growth rather than fabI.
Based on the above data, we propose minimum transcript level
50 (MTL50) as a measure of stringent requirement, somewhat
similar to the IC50 measure of enzyme inhibition. MTL50 values
directly reflect the relationship between the level of a particular
mRNA and growth rate decline, thus indicating how stringently
required an essential gene is for growth. By plotting the values of
relative growth rate against relative mRNA level for each gene on
the same graph, we are able to estimate the value of relative
mRNA (MTL50) at 50% growth rate (Figure 5). We observed that
a shift to the right indicates greater stringency as the minimum
level of transcript needed to sustain 50% cell viability increases.
Hence, a high MTL50 value indicates high gene stringency. This is
because the value indicates the minimum required level of
transcript for viability, not the minimum inhibition level of
transcript, and hence differs from IC50 in this respect. Compar-
isons of the MTL50 values, determined by the two different gene-
silencing methods, are shown in Figure 6. In general, MTL50
values were higher in the expressed antisense cultures compared to
antisense PNA treated cultures. Both methods found that the most
stringently required essential gene was acpP, followed by ftsZ.
Antisense PNA silencing showed fabI to be the least stringent,
whereas expressed antisense silencing found murA was significantly
less stringently required, relative to the other four essential genes
examined (Figures 5 and 6).
Discussion
Cell growth and mRNA profiles following expressed antisense
RNA silencing differed somewhat from those following antisense
PNA silencing, possibly reflecting different mechanisms of
silencing. Nevertheless, the data reject the null hypothesis of equal
stringent requirement for growth essential genes and support our
premise that essential genes differ in their level of requirement for
growth. Indeed, both RNA silencing methods indicate significant
differences in gene stringency and reveal acpP as the most
stringently required essential gene, followed by ftsZ, out of the
four that were studied. As the MTL50 value of each gene is
calculated relative to appropriate unsilenced controls, differences
in basal expression of the different essential genes will not affect the
stringency ranking.
The stringency ranking of murA and fabI differed between PNA-
treated cells and antisense-expressing cells, probably because of
differences between PNA and RNA chemistry, size differences
between the two types of silencers and subtle differences in the
mechanisms of gene silencing. For example, antisense PNAs act
directly through steric hindrance of translation initiation and may
indirectly trigger decay of repressed transcripts, whereas antisense
RNAs may act both by steric hindrance and by direct activation of
dsRNA-mediated cleavage at the target site. Ideally, protein
quantification should be carried out in parallel with RT-PCR,
however, biochemical assays to confirm antisense inhibition of
acpP, fabI, ftsZ and murA were not carried out due to the technical
difficulties involved in harvesting sufficient culture biomass and
quantitative protein assays are lacking for many genes of interest.
Current methods are limited to the use of antibodies [33,43] or
intracellular peptide expression [44]. Nevertheless, correlation
between mRNA and protein levels in bacteria has been
demonstrated for some genes [25,39,45,46,47], suggesting that
the MTL values reported here provide a useful measure of gene
requirement.
Four genes were compared in this study and only acpP does
not encode for an enzyme. However, the finding of acpP being
more critically required than ftsZ, fabI and murA is not entirely
surprising. ACP is known to interact with a large number of
proteins in the fatty acid biosynthesis pathway [5] and reduction
in levels of active ACP results in cell toxicity [33,36]. In
addition, ACP interacts with proteins not involved in lipid
synthesis [48]. Therefore, ACP is needed in large quantities and
a slight decrease in ACP levels may be amplified through its
interacting partners, leading to widespread physiological effects.
Indeed, acpP transcripts and protein products are abundant in E.
coli [49,50]. FtsZ was recently found to have GTPase activity
[51], however, it interacts with at least four proteins and is a
component of the complex divisome [52]. From the point of
view of gene product regulation, FtsZ concentrations dictate the
initiation of cell division through interaction with FtsA and FtsQ
[53]. In contrast, FabI and MurA interact with fewer proteins
[5] possibly because they catalyze specific reactions. Also, FabI is
the catalytic end point in fatty acid elongation and is subject to
feedback inhibition by acyl-ACP in the fatty acid elongation
cycle [54], and MurA is the catalytic starting point in
peptidoglycan assembly [27] and may be regulated through
feedback inhibition by UDP-N-acetylmuramic acid, a down-
stream product in the pathway [55]. Hence, it can be argued
that changes in ACP or FtsZ levels are less tolerated than
changes in FabI and MurA levels.
Specific control of single gene expression within a bacterial
operon remains a challenge due to the polycistronic nature of
transcripts. Indeed, antisense PNAs targeting genes of the lac
operon have polar effects on transcript stability and translation
[39]. To avoid this problem, we selected genes that are less likely
to be affected: fabI and murA are predicted by RegulonDB
(regulondb.ccg.unam.mx) and EcoCyc (http://ecocyc.org/) to be
individually transcribed, ftsZ, which is at the 39 end of an operon
[24], and acpP, which is transcribed either alone or with fabF [25],
a non-essential gene involved in thermal regulation of fatty acid
biosynthesis [56]. We note that the potency of the acpP-specific
PNA may be due to inhibition of fabF expression as well, although
this seems unlikely, as it has been reported that tandem mutation
Table 1. Properties of PNA used in this study.
PNA Sequence Target Target location* and length Reference/source
Ec107 (KFF)3K-eg1-cccatagctt fabI 25t o+5 (10 nt.) [11]
Ec108 (KFF)3K-eg1-ctcatactct acpP 25t o+5 (10 nt.) [57]
Ec326 (KFF)3K-eg1-tcaaacatag ftsZ 22t o+8 (10 nt.) This study
Ec330 (KFF)3K-eg-1-tttagtttgt murA 29t o+1 (10 nt.) This study
*Antisense target locations are indicated relative to the start codon.
doi:10.1371/journal.pone.0006061.t001
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e6061Figure 2. Dose dependent growth inhibition of antisense PNA-treated AS19 cells. Overnight AS19 cultures were sub-cultured in fresh media
containing different PNA doses for each gene, and its growth monitored by turbidity. Six doses were chosen for each PNA, so as to obtain a titration in
growth inhibition. Growth profiles terminated when all cultures were harvested at DOD550,0.1 of the untreated culture, for transcript analyses.
doi:10.1371/journal.pone.0006061.g002
E. coli Gene Stringency
PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e6061in another gene (fabB) is needed for growth inhibition [56], and
anti-acpP effects are rescued by plasmid acpP transcomplementa-
tion [37].
In summary, our results show essential genes are differentially
required and their requirement level appears to reflect the extent
of predicted protein-protein interactions. Both PNA and
expressed antisense gene silencing methods gave similar results,
despite having different inhibitory mechanisms. Therefore RNA
silencing can be used to confirm and quantify essential gene
requirement and serve as a molecular pre-screen, before
investing in a search for specific inhibitors. It may also provide
a useful tool for identifying reference genes for quantitative
transcript profiling.
Materials and Methods
Bacteria and growth conditions for specificity testing of
antisense agents
E. coli strain DH5a (Invitrogen) was transformed with
recombinant plasmids pBAD-fabI, pBAD-acpP, pBAD-ftsZ and
pBAD-murA (Table 2 and below) and clones were used for testing
the specificity of gene silencing either by PNA treatment or
antisense expression. Overnight E. coli cultures were standardized
by OD550 readings to approximately 2610
4 cfu/ml. To test the
specificity of antisense PNA, clones were grown in Mueller-Hinton
broth (MHB; Oxoid) supplemented with ampicillin (100 mg/ml)
and 4 mM of gene-specific antisense PNA in aqueous solution,
either with or without 0.02–0.2% L-arabinose (Sigma) for
induction of essential gene over-expression. Concentrations of L-
arabinose were optimized for each clone.
To test expressed antisense specificity, clones containing both
essential gene over-expressing plasmid and antisense-expressing
plasmid (see below) were grown in MHB supplemented with
ampicillin (100 mg/ml) plus chloramphenicol (30 mg/ml) and 0.1–
75 mM IPTG (for induction of expressed antisense), either with or
without 0.02–0.2% L-arabinose for induction of essential gene
over-expression. Concentrations of IPTG and L-arabinose were
optimized for each clone. Bacterial cultures were grown in a Bio-
Tek PowerWave X340 spectrophotometer at 37uC with agitation
every 5 min in 200 ml volumes in a 96-well plate. Growth was
monitored by OD550 readings every 5 min. Each experiment was
performed in triplicate.
Plasmids and strains used for testing specificity of
antisense agents
The ORFs of the four essential genes were cloned into the
multiple cloning site (MCS) of pBAD/HisA vector (Invitrogen),
allowing gene over-expression from the L-arabinose-inducible
promoter. Sequences were amplified from K12 genomic DNA
using primers acpP-OF/R, ftsZ-OF/R, murA-OF/R and fabI-
OF/R, specific for acpP, ftsZ, murA and fabI, respectively (Table
S1). Amplicons were digested with NcoI and XhoI (Fermentas) and
cloned into the pBAD/HisA vector containing similarly digested
ends. Recombinant plasmids were transformed into E. coli DH5a
cells and selected on LB plates supplemented with ampicillin
(100 mg/ml). Clones were then used for testing specificity of the
PNA treatment. For testing specificity of the expressed antisense,
clones containing either pBAD-fabI, pBAD-acpP, pBAD-ftsZ or
pBAD-murA were further transformed with respective antisense-
carrying plasmid, i.e. pHN682, pHNA, pHNZ or pHNM (Table 2
and below), and selected on LB plates supplemented with
ampicillin (100 mg/ml) and chloramphenicol (30 mg/ml).
Bacteria, growth conditions, PNA treatment and
antisense expression for gene silencing
E. coli strain AS19 with a hyper-permeable phenotype was used
in PNA treatments (total of 6 doses; Table 1) [40]. AS19 cultures
in Mueller-Hinton broth (DIFCO) used for PNA (Panagene,
Korea) treatments were prepared as described previously [57], and
PNA concentrations (0–110 nM) were optimized for a titration in
growth inhibition. TOP10 E. coli (Invitrogen) was used in
transformation reactions of plasmids expressing antisense sequenc-
es (Table 2). Antisense expression was induced by various
concentrations of IPTG (total of 6 doses) added to LB
supplemented with chloramphenicol (30 mg/ml; Sigma). Over-
night cultures of antisense-expressing clones were standardized by
OD550 readings to approximately 2610
5 cfu/ml for IPTG
induction. For antisense PNA treatment and IPTG induction,
20 ml of the appropriate PNA or IPTG concentration in aqueous
solution was deposited into each well of a 96 well plate before the
addition of E. coli in liquid culture to a final volume of 200 ml.
Bacterial cultures were then grown in a VERSAmax spectropho-
tometer at 37uC with agitation for 5 s every 5 min. Growth was
monitored by OD550 readings every 5 min and all cultures were
harvested when the untreated control increased in turbidity of
Table 2. Plasmids used in this study.
Plasmid Relevant characteristic Purpose
Antisense target location*
and length
Reference/
source
pBAD/HisA Arabinose inducible promoter (PBAD), Amp
R Inducible expression of essential genes n.a. Invitrogen
pBAD-fabI fabI ORF Inducible over-expression of fabI n.a This study
pBAD-acpP acpP ORF Inducible over-expression of acpP n.a. This study
pBAD-ftsZ ftsZ ORF Inducible over-expression of ftsZ n.a This study
pBAD-murA murA ORF Inducible over-expression of murA n.a. This study
pHN678 IPTG inducible promoter (Ptrc),
paired-termini flanking MCS, Cam
R
Stabilized antisense expression vector n.a. [12]
pHN682 fabI antisense insert Inducible expression of fabI antisense 274 to +86 of fabI (160 nt.) [12]
pHNA acpP antisense insert Inducible expression of acpP antisense 242 to +85 of acpP (127 nt.) This study
pHNZ ftsZ antisense insert Inducible expression of ftsZ antisense 253 to +76 of ftsZ (129 nt.) This study
pHNM murA antisense insert Inducible expression of murA antisense 254 to +76 of murA (130 nt.) This study
*Antisense target locations are indicated relative to the start codon.
doi:10.1371/journal.pone.0006061.t002
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PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e6061Figure 3. Gene silencing in E. coli to obtain a titration of declining growth rates and transcript levels by antisense PNA and expressed
antisense. E. coli AS19 was treated with PNA doses, while TOP10 clones containing antisense-expressing plasmids were induced with various IPTG
concentrations as shown in Figure 2, so as to obtain growth inhibition in a dose-dependent manner. Total RNA from E. coli cultures was harvested at the
time when the control culture increased in OD550 by 0.1. RNA was used for cDNA synthesis and quantitative real-time PCR to determine mRNA levels by
normalization to a reference gene rpoA, and then calculated relative to the unsilenced (untreated) control. Growth rates were determined by OD550
readings over time. The relationship between mRNA and growth rate decline indicated growth requirement stringency of each gene.
doi:10.1371/journal.pone.0006061.g003
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PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e6061Figure 4. Effect of gene silencers on cell morphology. Cells were stained with DAPI before fluorescent microscopy. Left panel: AS19 untreated
or treated with antisense PNA Ec108 (20 nM) targeting acpP, Ec107 (80 nM) targeting fabI, Ec326 (70 nM) targeting ftsZ or Ec330 (55 nM) targeting
murA. Gross elongation of cells was observed only in cultures treated with ftsZ-specific PNA, Ec326. Right panel: TOP10 clones uninduced or induced
with IPTG for antisense RNA expression. Concentrations of IPTG used for induction of acpP-, fabI-, ftsZ- and murA-antisense expression were 160 mM,
130 mM, 80 mM and 80 mM, respectively. Cells expressing ftsZ-antisense were grossly elongated compared to other cells.
doi:10.1371/journal.pone.0006061.g004
Figure 5. Determining the MTL50 value of each gene. For each gene, mean relative mRNA and growth rate values from Figure 3 were
transformed so that mean relative mRNA values were plotted against corresponding mean values of relative growth rates to obtain a curve. The curve
of each gene allows an estimation of a transcript value (on the x-axis) at a growth reduction of 50% (y=0.5), that is, the MTL50 value of the gene of
interest. The MTL50value reveals stringency of an essential gene for growth.
doi:10.1371/journal.pone.0006061.g005
E. coli Gene Stringency
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and cells were pelleted for RNA extraction. Growth rate was
calculated as DOD/Dt.
Design of antisense PNA for gene silencing
Antisense PNA specific for acpP (Ec108), fabI (Ec107), ftsZ
(Ec326) and murA (Ec330) were designed using optimal parameters
for gene silencing [37,38] (Table 1). Briefly, these parameters are:
9–12 mer PNA of an antisense sequence targeting the region of
210 to +10 around the start codon and conjugated to a cell wall-
permeating peptide (KFF)3K. Candidate antisense sequences
within the stated start codon region were checked for sequence
uniqueness in similar regions using an E. coli database (http://
genolist.pasteur.fr/Colibri/) before testing antisense inhibition of
growth and gene expression, as described above and below.
Plasmid expressing antisense for gene silencing
Antisense sequences were chosen based on length, location (120–
160 nt around the start codon to include promoter and coding
regions) [12] and for minimal secondary structures, which were
predicted by RNAfold (http://www.tbi.univie.ac.at/RNA/RNA-
fold.html). Antisense sequences were cloned into the MCS of
pHN678, which is flanked by a 38 bp paired-termini to stabilize
antisense RNA inserts [12]. Antisense sequences of essential genes
wereamplifiedfromK12genomicDNAwithprimersacpP-XF1/R2,
ftsZ-XF5/R5 and murA-XF/R specific for acpP, ftsZ and murA,
respectively (Table S1). Amplicons were then digested with NcoIa n d
XhoI and cloned into pHN678 with similarly digested ends.
RecombinantplasmidsweretransformedinTOP10cellsandselected
on LB supplemented with chloramphenicol (30 mg/ml). The fabI
antisenseexpressing plasmid pHN682hasbeen described [12].
Fluorescence microscopy
E. coli AS19 cultures were either left untreated or treated with
sub-inhibitory (dose 3) and inhibitory (dose 6) concentrations of
PNA and then viewed by fluorescence microscopy. Similarly, E.
coli TOP10 cultures either left uninduced or induced with IPTG
for moderate (dose 3) or high expression (dose 6) of antisense
sequences were viewed microscopically. Cells were grown and
harvested as described above, where 1 ml of cells were pooled and
pelleted. Cells were washed once in an equal volume of 16PBS,
suspended in 100 mlo f1 6PBS, and stained with DAPI (1 mM) for
5 min. Cells were viewed at 10006magnification in a Leica
DMRA2 microscope and images were captured and processed
using Openlab software version 3.1.4.
RNA extraction, reverse transcription and qPCR
Extraction of RNA from bacterial cells, followed by DNase I
treatment were carried out using the RiboPure Bacteria Kit
(Ambion) according to the manufacturer’s protocol. RNA
(200–500 ng) was converted to cDNA in a 25 ml reaction
consisting of 16RT reaction buffer, 5.5 mM MgCl2, 0.5 mM
of each dNTP, 2.5 mM random hexamers, 0.4 U/ml RNase
inhibitor, and 1.25 U/ml MultiScribe Reverse Transcriptase
(Applied Biosystems). Each 25 ml of PCR reaction contained
12.5 ml of SYBR Green PCR buffer (Eurogentec), 100 nM of
each primer (Biomers) and 5 ml of cDNA. Relative qPCR was
carried out with primers acpP-F/R, fabI-F/R, ftsZ-F/R,
murA-F/R specific for acpP, fabI, ftsZ and murA, respectively,
as the target gene, and primers rpoA-F/R specific for rpoA as
the reference gene (Table S1). Target and reference primer
pairs were validated for amplification efficiencies for real time
data analyses, either by the 2
-DDCT method [58] for primers
with similar efficiencies, or the 2
DCT (target)/2
DCT (reference)
method for primers with different efficiencies [59] for relative
qPCR. Quantitation of acpP, fabI, ftsZ and murA mRNA was
normalized against rpoA mRNA and calculated relative to the
untreated sample. Mean values with error bars, representing
standard deviation from three experimental replicates, were
plotted against PNA or IPTG doses.
Figure 6. Analysis of essential gene MTL50 values. Three curves from triplicate experiments of each gene were plotted so as to obtain three
MTL50 values for statistical analyses. Significant difference (**=p,0.01, *=p,0.05) in MTL50 between genes was determined by a one-way ANOVA
and Tukey HSD Test. Antisense PNA silencing (left panel) showed MTL50 of acpP to be significantly greater than the other three genes. Expressed
antisense RNA silencing (right panel) showed MTL50 of acpP and ftsZ was significantly greater than that of murA only.
doi:10.1371/journal.pone.0006061.g006
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For each gene, data points from DOD/Dt per PNA or IPTG
concentration (Figure 2) were plotted against relative mRNA per
PNA or IPTG concentration (Figure 2) on a new graph. This
results in a curve of relative DOD/Dt against relative mRNA for
each gene, from which the MTL50 is estimated. The x-axis value
where the curve intersects y=0.5 (for 50% reduction in growth)
gives the MTL50 value. As each experiment was carried out in
triplicate, each gene had three curves from PNA treatment and
three curves from expressed antisense experiments. For simplicity,
only mean data resulting in an average curve for each gene is
shown in Figure 3. Triplicate MTL50 values, estimated from
triplicate curves, were used for statistical analysis in Figure 6.
Statistical analysis
Statistical analyses of R
2 for correlation, mean6SD and
ANOVA were carried out using Excel. Tukey HSD Test for
post-ANOVA comparisons was calculated at http://faculty.vassar.
edu/lowry/hsd.html
Supporting Information
Table S1 Primers used in this study.
Found at: doi:10.1371/journal.pone.0006061.s001 (0.06 MB
DOC)
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